On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Ubiquitination vs. phosphorylation (1)
- Ubiquitination vs. phosphorylation (2)
- Ubiquitination vs. phosphorylation (3)
- Ubiquitin-binding domains
- Ubiquitination vs. phosphorylation (4)
- Ubiquitin signaling in the NF-kappaB pathway
- NF-kappaB signaling pathway
- The biochemical pathway of IkB ubiquitination (1)
- The biochemical pathway of IkB ubiquitination (2)
- The IL-1R/toll-like receptor pathway
- TRAF-6, Nemo-dependent IKK activation in vitro
- Activation of IKK by TRAF6 requires two factors
- TRAF6-regulated IKK activator-2
- Ubc13 is required for IKK activation by IL-1beta
- Catalytic activity of Ubc13
- TRIKA1 = Ubc13/Uev1A
- Domain organization of TRAFs
- TRAF6 is a ubiquitin ligase
- Polyubiquitin chains
- K63-linked polyUb chains mediate IKK activation
- Human ubiquitin genes
- An inducible ubiquitin "knock-in" system
- K63 is required for IKK activation by IL-1beta
- TRIKA2 = TAK1/TAB1/TAB2
- Ubiquitin activation of stress kinases
- The proposed model
- The CYLD and NEMO pathologies
- Innate and adaptive immunity
- Acknowledgement
Topics Covered
- Ubiquitination is a reversible covalent modification, akin to phosphorylation
- Ubiquitination regulates protein kinase activity through proteasome-independent mechanisms
- K63-linked polyubiquitination activates TAK1 and IKK in the NF-kappaB pathway
- Deubiquitination enzymes inhibit protein kinases in the NF-kappaB pathway
- Protein kinase regulation by ubiquitin is important in innate and adaptive immunity
Talk Citation
Chen, Z.'. (2010, November 30). The interplay between protein phosphorylation and ubiquitylation in the NF-κB pathway [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 19, 2025, from https://doi.org/10.69645/PGQM8626.Export Citation (RIS)
Publication History
- Published on November 30, 2010
Financial Disclosures
- Prof. Zhijian 'James' Chen has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The interplay between protein phosphorylation and ubiquitylation in the NF-κB pathway
Published on November 30, 2010
30 min
A selection of talks on Biochemistry
Hide